| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $3.48B | +12.6% |
| R&D Expense | $277.9M | +22.4% |
| SG&A Expense | $734.6M | +7.0% |
| Operating Income | $136.8M | +36.7% |
| Interest Expense | $234.2M | -4.5% |
| Pre-tax Income | -$106.0M | +28.1% |
| Income Tax | -$48.6M | -38.2% |
| Net Income | -$57.4M | +48.9% |
| EPS (Basic) | -$0.18 | +48.6% |
| EPS (Diluted) | -$0.18 | +48.6% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $252.3M | +123.1% |
| Accounts Receivable | $720.1M | -1.7% |
| Current Assets | $1.31B | +17.3% |
| Total Assets | $9.93B | -1.8% |
| Current Liabilities | $1.08B | +3.1% |
| Long-term Debt | $4.65B | -4.2% |
| Total Liabilities | $6.66B | -3.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $696.9M | +18.9% |
| Investing Cash Flow | -$276.9M | +51.2% |
| Financing Cash Flow | -$280.9M | +11.9% |
| Stockholders' Equity |
| $3.28B |
| +0.7% |